Journal Article

DZNE-2022-00302

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3.

Guedj, E. ; Varrone, A. ; Boellaard, R. ; Albert, N. L. ; Barthel, H. ; van Berckel, B. ; Brendel, M.DZNE* ; Cecchin, D. ; Ekmekcioglu, O. ; Garibotto, V. ; Lammertsma, A. A. ; Law, I. ; Peñuelas, I. ; Semah, F. ; Traub-Weidinger, T. ; van de Giessen, E. ; Van Weehaeghe, D. ; Morbelli, S.

2022
Springer-Verl. Heidelberg [u.a.]

This record in other databases:    

Please use a persistent id in citations: doi:10.1007/s00259-021-05603-w

Abstract: The present procedural guidelines summarize the current views of the EANM Neuro-Imaging Committee (NIC). The purpose of these guidelines is to assist nuclear medicine practitioners in making recommendations, performing, interpreting, and reporting results of [18F]FDG-PET imaging of the brain. The aim is to help achieve a high-quality standard of [18F]FDG brain imaging and to further increase the diagnostic impact of this technique in neurological, neurosurgical, and psychiatric practice. The present document replaces a former version of the guidelines that have been published in 2009. These new guidelines include an update in the light of advances in PET technology such as the introduction of digital PET and hybrid PET/MR systems, advances in individual PET semiquantitative analysis, and current broadening clinical indications (e.g., for encephalitis and brain lymphoma). Further insight has also become available about hyperglycemia effects in patients who undergo brain [18F]FDG-PET. Accordingly, the patient preparation procedure has been updated. Finally, most typical brain patterns of metabolic changes are summarized for neurodegenerative diseases. The present guidelines are specifically intended to present information related to the European practice. The information provided should be taken in the context of local conditions and regulations.

Keyword(s): Brain: diagnostic imaging (MeSH) ; Brain: metabolism (MeSH) ; Fluorodeoxyglucose F18: metabolism (MeSH) ; Humans (MeSH) ; Nuclear Medicine (MeSH) ; Positron-Emission Tomography (MeSH) ; Tomography, X-Ray Computed (MeSH) ; Dementia ; Encephalitis ; Epilepsy ; Glioma ; Glucose ; Lymphoma ; Metabolism ; Movement disorders ; Oncology ; PET ; Psychiatry ; Fluorodeoxyglucose F18

Note: (CC BY)

---

Contributing Institute(s):

1. ALS, FTLD and Zebrafish models (AG Haass old)

Research Program(s):

1. 352 - Disease Mechanisms (POF4-352) (POF4-352)

Appears in the scientific report 2022

---

Database coverage:
; ; ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; DEAL Springer ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 10 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---

---

Linked articles:

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article (Erratum/Correction) Guedj, E. ; Varrone, A. ; Boellaard, R. ; Albert, N. L. ; Barthel, H. ; van Berckel, B. ; Brendel, M.DZNE* ; Cecchin, D. ; Ekmekcioglu, O. ; Garibotto, V. ; Lammertsma, A. A. ; Law, I. ; Peñuelas, I. ; Semah, F. ; Traub-Weidinger, T. ; van de Giessen, E. ; Van Weehaeghe, D. ; Morbelli, S.
Correction to: EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3
European journal of nuclear medicine and molecular imaging 49(6), 2100 - 2101 (2022) [10.1007/s00259-022-05755-3]2022   Files  Fulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

---